Viewing Study NCT03333018


Ignite Creation Date: 2025-12-25 @ 4:35 AM
Ignite Modification Date: 2026-01-20 @ 3:37 PM
Study NCT ID: NCT03333018
Status: COMPLETED
Last Update Posted: 2018-02-22
First Post: 2017-10-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module